Expert Review of Anti-Infective Therapy

Papers
(The H4-Index of Expert Review of Anti-Infective Therapy is 31. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
An update on COVID-19 pandemic: the epidemiology, pathogenesis, prevention and treatment strategies172
Azithromycin in the treatment of COVID-19: a review160
COVID-19 and cardiac injury: clinical manifestations, biomarkers, mechanisms, diagnosis, treatment, and follow up153
Resolution of coronavirus disease 2019 (COVID-19)116
An overview of tecovirimat for smallpox treatment and expanded anti-orthopoxvirus applications104
The use of IV vitamin C for patients with COVID-19: a case series98
Sepsis-associated encephalopathy and septic encephalitis: an update95
Antimicrobial resistance in low- and middle-income countries: current status and future directions87
Exercise and well-being during COVID 19 – time to boost your immunity77
Quorum quenching enzymes and their effects on virulence, biofilm, and microbiomes: a review of recent advances76
Functionalized carbon-based nanomaterials and quantum dots with antibacterial activity: a review71
Meropenem/vaborbactam: a next generation β-lactam β-lactamase inhibitor combination65
Can nanotechnology help in the fight against COVID-19?65
COVID-19: fighting the invisible enemy with microRNAs63
Calycosin: a Review of its Pharmacological Effects and Application Prospects62
Moxidectin: an oral treatment for human onchocerciasis53
Virulence factors, antibiotic resistance patterns, and molecular types of clinical isolates of Klebsiella Pneumoniae51
CAR-T cell therapy and infection: a review49
Update on the epidemiology of carbapenemases in Latin America and the Caribbean48
Point prevalence surveys of antimicrobial use: a systematic review and the implications47
COVID-19 and vitamin D (Co-VIVID study): a systematic review and meta-analysis of randomized controlled trials45
Current and emerging strategies to combat antimalarial resistance44
Antimicrobial consumption in patients with COVID-19: a systematic review and meta-analysis44
Old and re-purposed drugs for the treatment of COVID-1944
Cytokine storm associated coagulation complications in COVID-19 patients: Pathogenesis and Management42
Progress on the national action plan of Pakistan on antimicrobial resistance (AMR): a narrative review and the implications36
MATH+ protocol for the treatment of SARS-CoV-2 infection: the scientific rationale35
Loss of smell and taste: a new marker of COVID-19? Tracking reduced sense of smell during the coronavirus pandemic using search trends34
Antimicrobial peptides and other peptide-like therapeutics as promising candidates to combat SARS-CoV-233
Bacterial death from treatment with fluoroquinolones and other lethal stressors33
Tackling Antimicrobial Resistance by promoting Antimicrobial stewardship in Medical and Allied Health Professional Curricula32
Antibiotic resistant bacteria: current situation and treatment options to accelerate the development of a new antimicrobial arsenal31
A point prevalence survey of antimicrobial utilisation patterns and quality indices amongst hospitals in South Africa; findings and implications31
All-cause mortality rates in adults with carbapenem-resistant Gram-negative bacterial infections: a comprehensive review of pathogen-focused, prospective, randomized, interventional clinical studies31
0.082905769348145